
Chris Molloy to address UK’s role in global drug development at Drug Discovery Innovators & Investors Conference
Chris Molloy, Chief Executive Officer of the UK BioIndustry Association (BIA), will explore the UK’s role in the changing global drug R&D landscape in his keynote address at the Drug Discovery Innovators & Investors (DDII) UK Conference on 4 November 2026 at etc.venues Monument, London, UK. Read More













